Evidence map›Paper›PMID 19038779›Full record

ArticleThe Journal of pharmacology and experimental therapeutics2009

Cocaine alters vesicular dopamine sequestration and potassium-stimulated dopamine release: the role of D2 receptor activation.

Sarah J Farnsworth, Trent J Volz, Glen R Hanson, Annette E Fleckenstein

Open access · bronzeAbstract read
In one paragraph

Article in The Journal of pharmacology and experimental therapeutics, 2009. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers.

0numbers the graph read from it
0cells of the map it votes in
18citing papers in PubMed
0.8field-weighted citation impact, top 33% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

18 citing papers in PubMed, 23 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Article
  6. Review
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Review
  13. Article
  14. Article
  15. Vesicular and plasma membrane transporters for neurotransmitters.Cold Spring Harbor perspectives in biology · 2012
    Review
  16. Monoamine transporters: vulnerable and vital doorkeepers.Progress in molecular biology and translational science · 2011
    Review
  17. Article
  18. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

Sarah J FarnsworthDepartment of Pharmacology and Toxicology, University of Utah, Salt Lake City, UT 84112, USA.
Trent J Volz
Glen R Hanson
Annette E Fleckenstein
University of Utah · US

Funding

Vmat AND NEUROTOXICITYP01DA013367 · NIDA · UNIVERSITY OF UTAH · PI HANSON, GLEN R · 2001 to 2012
$10.1M
DRUG ABUSE &REGULATORY ENZYMES OF BIOGENIC AMINESR01DA000869 · NIDA · UNIVERSITY OF UTAH · PI FLECKENSTEIN, ANNETTE · 1985 to 2010
$2.9M
Psychostimulants and Monoamine TransportersR01DA011389 · NIDA · UNIVERSITY OF UTAH · PI FLECKENSTEIN, ANNETTE · 2003 to 2012
$2.5M
NEUROCHEMICAL ALTERATIONS BY DESIGNER DRUGSR01DA004222 · NIDA · UNIVERSITY OF UTAH · PI HANSON, GLEN R · 1986 to 2010
$2.0M
K02 ApplicationK02DA019447 · NIDA · UNIVERSITY OF UTAH · PI FLECKENSTEIN, ANNETTE · 2005 to 2014
$1.3M
Pharmacology and Toxicology of Methamphetamine Abuse (K05 DA00378)K05DA000378 · NIDA · UNIVERSITY OF UTAH · PI HANSON, GLEN R · 1998 to 2011
$1.2M
METHAMPHETAMINE AND DOPAMINE TRANSPORTERSR29DA011389 · NIDA · UNIVERSITY OF UTAH · PI FLECKENSTEIN, ANNETTE · 1998 to 2002
$329k
NIDA NIH HHS DA00378NIDA NIH HHS DA00869NIDA NIH HHS DA019447NIDA NIH HHS DA04222NIDA NIH HHS DA11389NIDA NIH HHS DA13367NIDA NIH HHS K02 DA019447NIDA NIH HHS K05 DA000378NIDA NIH HHS P01 DA013367NIDA NIH HHS R01 DA000869NIDA NIH HHS R01 DA004222NIDA NIH HHS R01 DA011389
6 · The paper itself

Abstract

Cocaine is a psychostimulant that inhibits the inward transport of dopamine (DA) via the neuronal DA transporter, thereby increasing DA concentrations in the synaptic cleft. Cocaine administration also causes a redistribution of striatal vesicular monoamine transporter (VMAT)-2-containing vesicles that co-fractionate with synaptosomal membranes after osmotic lysis (referred to herein as membrane-associated vesicles) to a nonmembrane-associated, cytoplasmic subcellular fraction. Although previous studies from our laboratory have focused on the impact of cocaine on cytoplasmic vesicles, the present report describes the pharmacological effects of cocaine on the membrane-associated vesicle population. Results revealed that the redistribution of VMAT-2 and associated vesicles away from synaptosomal membranes is associated with a decrease in total DA transport and DA content in the membrane-associated VMAT-2-containing subcellular fraction. Cocaine also decreases the velocity and magnitude of K+-stimulated exocytotic DA release from whole striatal suspensions. The cocaine-induced VMAT-2 redistribution, decrease in DA release, and decrease in total DA transport are mediated by D2 receptors as these events were prevented by pretreatment with the D2 receptor antagonist, eticlopride [S-(-)-3-chloro-5-ethyl-N-[(1-ethyl-2-pyrrolidinyl)methyl]-6-hydroxy-2-methoxybenzamide hydrochloride]. These data suggest that after cocaine administration, D2 receptors are activated because of increased synaptic DA, resulting in a redistribution of DA-containing vesicles away from synaptosomal membranes, thus leading to less DA released after a depolarizing stimulus. These findings provide insight into not only the mechanism of action of cocaine but also mechanisms underlying the regulation of dopaminergic neurons.

Indexed as

AnimalsCell MembraneCocaineCorpus StriatumDopamineElectric StimulationMalePotassiumRatsRats, Sprague-DawleyReceptors, Dopamine D2Synaptic VesiclesVesicular Monoamine Transport ProteinsCocaineDopaminePotassiumReceptors, Dopamine D2Slc18a2 protein, ratVesicular Monoamine Transport Proteins

Identifiers

PMID19038779
PMCPMC2682259
OpenAlexW2110913474

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.